How to evaluate a custom clinical-trial integration
Record ownership, access route, CDISC/FHIR/terminology fit, validation evidence, reconciliation output, and rollout scope before credentials move.
Resources
Useful field notes for teams that run modern trials.
Practical reads on clinical operations, Part 11, eTMF completeness, site operations, safety review, AI control, and inspection readiness. Each piece teaches the clinical problem first, then maps the evidence pattern back to Clinistack.
Reading queue
Teach the work, then show the product path.Featured reads
Start with articles trial teams can actually use.
The first resource set reads like useful field notes, not filler downloads. Each article explains the clinical operating problem, the evidence question, and the Clinistack pattern that resolves it.
What Part 11 changes when AI enters regulated work
Mode 2 suggestions, AI Data Contracts, reviewer authority, fallback, retained artifacts, and regulated-write boundaries.
Why eTMF completeness fails late
Expected-document logic, amendment drift, site exchange, lifecycle state, country-language variants, and inspection timing.
Delegation is access control, not an appendix
DOA, training currency, signature evidence, procedure eligibility, access scope, and protocol-deviation risk.
Protocol amendments as a trial-wide event
How one protocol change reaches consent, eTMF, EDC, RTSM, monitoring, training, safety, and site readiness.
Library
Organize the library by the diligence problem.
Resources make the public site useful before a sales conversation. The taxonomy mirrors the questions clinical operations, quality, IT, safety, and site teams bring.
Integration architecture
System exchange, record ownership, custom sources, standards-first mapping, migrations, exchange packages, and reconciliation.
Compliance evidence
Part 11, audit trails, signature manifestations, validation records, WORM posture, access review, and inspection artifacts.
Clinical operations
CTMS, site activation, DOA, training, RBM, monitoring, amendments, eTMF, site exchange, and inspection preparation.
AI in regulated workflows
AI Data Contracts, Mode 2 review, model provenance, fallback, reviewer disposition, and high-risk automation boundaries.
Safety and medical review
SAE context, aware-date discipline, MedDRA and WHODrug terminology, E2B(R3), medical monitoring, and QPPV visibility.
Editorial standard
Every resource earns its place.
The standard is simple: teach something a clinical operator would forward to operations, quality, IT, safety, or a Site lead before a sales call.
Teach the problem
Open with the clinical operating failure: late completeness, hidden source drift, manual reconciliation, unclear delegation, or review bottlenecks.
Name the evidence
Show the artifact an inspector, security reviewer, quality lead, or site team would use to decide whether the process is controlled.
Tie back to the platform
End with the Clinistack pattern: record ownership, controlled workflow, retained evidence, audit trail, and reviewable output.
First rollout
Bring the study question your team keeps rebuilding.
We will review the product path, system context, owners, evidence, and rollout approach that fit the trial work in front of you.